"CyberRx automates the new NIST Cybersecurity Framework in a...

"CyberRx automates the new NIST Cybersecurity Framework in a
unique way that allows companies to measure their cybersecurity capabilities, quantify their potential
financial liability, and reduce their cybersecurity risk exposure."

I Would imagine getting a few more checks along with what NSIT can offer itself, is a better outcome for the company. Not a price sensitive announcement I know, but just gives them more justification of the growth path they are on in the US and shows their technology works. Which a lot of posters on here seem to always questions. So TLS are happy to sell it, I assume they think it works, CyberRx have tested Launchpad and they say it works and is cost effective, so I take it as something is working...Cash flow will come...